NEW DELHI: As India prepares for the world’s largest vaccination program, India’s Controller General of Drugs (DCGI) on Sunday quelled rumors surrounding Covid-19 vaccines regarding impotence, dismissing those speculations as “complete nonsense”. “We will never approve anything if there is the slightest concern for safety. Vaccines are 110% safe. Some …
Read More »
Delhi’s Health Minister Satyendar Jain said on Sunday that frontline and healthcare workers will receive the coronavirus disease (Covid-19) vaccine in the first phase in the national capital, even as the Comptroller General Drug Commission of India gave final approval for the emergency. use of Oxford University-AstraZeneca and Bharat Biotech …
Read More »
NEW DELHI: Prime Minister Narendra Modi congratulated the nation on Sunday and thanked the scientific and health community after the Controller General of Drugs of India (DCGI) gave final approval to the Oxford-AstraZeneca and Covaxin Covishield vaccines from Bharat Biotech for emergency use. The announcement marks a “decisive turning point” …
Read More »
The other vaccine, known as COVAXIN, has been developed locally by Bharat Biotech and the government-run Indian Council for Medical Research. Reuters, citing sources, reported on Friday that the injection could be approved, although little is known about the results of its clinical trials. “Granting permission for restricted use in …
Read More »
The Government of India has granted approval in principle to two vaccines against Coronavirus, setting the stage for the deployment of the first phase of mass vaccination in the country. The Subject Matter Expert Committee (SEC) of the Central Organization for the Control of Medicines Standards recommended the granting of …
Read More »
NEW DELHI: An expert panel from India’s central drug authority on Saturday recommended granting permission for emergency use of the Covid-19 vaccine developed in the country Covaxin under certain conditions, a day after giving a similar address for the Oxford Covid-19 vaccine, the sources said. Covaxin has been developed indigenously …
Read More »
NEW DELHI: The launch of the vaccine in India will begin with the availability of two injections, Covishield from Oxford-Astra Zeneca and Covaxin homegrown from Bharat Biotech, and the Comptroller General of Drugs of India is expected to issue final approvals that they will probably be announced on Sunday. The …
Read More »
Bharat Biotech announced the successful recruitment of 23,000 volunteers and continued progress towards achieving the goal of 26,000 participants for the phase 3 clinical trial of its Covaxin coronavirus vaccine at multiple sites in India, the ANI news agency said citing the pharmaceutical firm on Saturday. The announcement came hours …
Read More »
Bharat Biotech vaccine candidate approved for use in clinical trial mode. The first COVID-19 vaccine developed in India, Covaxin, has been recommended for “restricted use in emergency situations, subject to multiple regulatory conditions” by the Subject Matter Expert Committee (SEC) of the Central Medicines Control Organization ( CDSCO), here on …
Read More »
NEW DELHI: An expert panel from India’s drug authority recommended Saturday restricted emergency use of Bharat Biotechis Covaxin. The development comes one day after the recommended panel. emergency use authorization for the Serum Institute of India’s (SII) Covishield. The Central Medicines Control Organization (CDSCO) Subject Matter Expert Committee (SEC) on …
Read More »